To Evaluate the Efficacy and Safety of Hearticelgram®-AMI in Patients With Acute Myocardial Infarction.
Condition(s):Acute Myocardial InfarctionLast Updated:October 22, 2021Unknown status
Hide Studies Not Open or Pending
Condition(s):Acute Myocardial InfarctionLast Updated:October 22, 2021Unknown status
Condition(s):Venous Thrombosis; Pulmonary Embolism; Atrial Fibrillation; Acute Coronary SyndromeLast Updated:September 23, 2021Completed
Condition(s):Renal Artery StenosisLast Updated:November 4, 2010Unknown status
Condition(s):Trophic Ulcers; Chronic Venous InsufficiencyLast Updated:November 1, 2018Completed
Condition(s):Atherosclerosis; Myocardial Ischemia; Myocardial InfarctionLast Updated:May 5, 2017Completed
Condition(s):Peripheral Artery Disease (PAD)Last Updated:July 19, 2017Terminated
Condition(s):HealthyLast Updated:May 5, 2011Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.